Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Case Report: COVID-19 with cytokine storm in a 16-year-old patient: if heart failures comes think about levosimendan
Veronica Rodriguez-Garcia1,2, Jose Luis Guerrero Orriach1,2,3, Daniel Ariza Villanueva1
1Department of Anaesthesia, Virgen de la Victoria University Hospital, Malaga, Spain.
Insights
This case study details a 16-year-old with septic shock and multi-organ failure initially suspected as lymphoproliferative syndrome, later diagnosed as hemophagocytic syndrome due to COVID-19 infection. Treatment with novel therapies led to recovery.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pediatric Cardiology
Background:
- COVID-19 can trigger severe systemic illness, including hemophagocytic syndrome and multi-organ failure.
- Distinguishing COVID-19 related complications from other critical conditions like lymphoproliferative disorders presents diagnostic challenges.
- Cytokine storm associated with severe COVID-19 can lead to cardiac dysfunction.
Abstract:
Introduction: Our case is unique because the differential diagnosis was a challenge. At first, the patient presented with septic shock and multi-organ failure in the context of a suspected lymphoproliferative syndrome. Once the lymphoproliferative process had been ruled out, hemophagocytic syndrome due to COVID-19 infection was suspected, so he is probably one of the few patients with such an exhaustive study that could contribute to our understanding of COVID-19. We followed therapeutic guidelines that differ from the usual, using adrenalin and levosimendan. Corticosteroids helped to modulate the cytokine storm. Case report: A 16-year-old adolescent was admitted to the intensive care unit with fever, diarrhea, multiorgan failure and septic shock. He was IgG positive for COVID-19 and IgM negative. Thoraco-abdominal computed tomography demonstrated multiple para-aortic and peri-pancreatic lymphadenopathy and acute respiratory distress syndrome. The first suspected diagnosis was a lymphoproliferative syndrome and bacterial infection. The second possibility was a hemophagocytic syndrome in a patient recovering from COVID-19. He was treated with broad spectrum antibiotics because the differential diagnosis was difficult, and we removed them when the microbiological screening was negative. During the course of the disease he presented with severe biventricular dysfunction, probably due to the cytokine storm, so we used inotropic drugs (adrenaline, levosimendan). Infection with Salmonella species group B was diagnosed later, when the patient was in the Internal Medicine ward, although he was asymptomatic. Conclusion: The severity of COVID-19 infection ranges from mild to severe, causing serious disease in some people. Although the pathophysiology is not well known, it seems that in some cases an immune storm is triggered, and it is related to more serious and prolonged disease. In our case, heart failure was important, because it could have worsened the prognosis. Fortunately, the response to levosimendan and corticosteroids was adequate and he recovered favorably until discharge.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cystic Fibrosis: Management
Sinus disease and chronic...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

